Stockwinners Market Radar for April 05, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:40 EDT Cathie Wood's ARK Investment bought 266K shares of SomaLogic today

20:38 EDT Cathie Wood's ARK Investment bought 214K shares of Unity today

20:28 EDT Extra Space Storage CEO sells $800K in common stock - In a regulatory filing, Extra Space Storage disclosed that its CEO Joseph Margolis sold 5K shares of common stock on March 4th in a total transaction size of $800.4K.

20:00 EDT Skillz CEO buys $836.3K in common stock - In a regulatory filing, Skillz disclosed that its CEO Andrew Paradise bought 1.5M shares of common stock on April 5th in a total transaction size of $836.3K. Shares of Skillz are up 8.2% afterhours.

19:01 EDT Samsung Electronics, AMD extend strategic IP licensing agreement - Samsung Electronics (SSNLF) and AMD (AMD) announced they have signed a multi-year agreement extension to bring multiple generations of high-performance, ultra-low-power AMD Radeon graphics solutions to an expanded portfolio of Samsung Exynos SoCs. Through the licensing extension, Samsung will bring console-level graphics quality and optimized power consumption to more mobile devices, offering an incredibly immersive and long-lasting gaming experience. "Together with AMD, Samsung has been revolutionizing mobile graphics, including our recent collaboration that brought ray tracing capability to mobile processors for the first time in the industry," said Seogjun Lee, executive vice president of Application Processor (AP) Development at Samsung Electronics. "Drawing on our technological know-how in designing ultra-low-power solutions, we will continue to drive ongoing innovation in the mobile graphics space."

18:32 EDT Ryman Hospitality reports Q1 occupancy at 72.3% - CEO Mark Fioravanti states: ""Given the uncertainty in today's economic environment, we wanted to provide an update on our preliminary operating performance for the first quarter. Driven by continued strength in our group segment, first quarter hotel operating performance greatly exceeded omicron-impacted 2022 as well as 2019 pre-pandemic levels. The first quarter saw occupancy of 72.3%, well ahead of first quarter 2022, and back to 2019 levels, even with 302 additional rooms at the Gaylord Palms. RevPAR grew 59% and 18% over the first quarter 2022 and 2019, respectively, driven by record first quarter ADR and strong outside the room spend as the number of group room nights traveled continued to increase. Looking ahead, our net group revenue on-the-books for April through December remains strong and continues to outpace both the 2022 and 2019 periods. In addition, our Opry Entertainment Group is capitalizing on robust demand, with preliminary revenue in the first quarter exceeding both 2022 and 2019. We remain excited about the strength of our business and look forward to continuing to execute on our operating and financial goals in the quarters and years ahead."

18:16 EDT Arrow Financial receives Nasdaq noncompliance notice - Arrow Financial Corporation announced that the company is noncompliant with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Annual Report on Form 10-K for the year ended December 31, 2022 with the Securities and Exchange Commission by the required due date As previously reported by the company in its Notification of Late Filing on Form 12b-25, filed with the SEC on March 16, 2023, as amended on March 31, 2023, the company was unable to timely file the Untimely Form 10-K without unreasonable effort or expense. The company intends to submit the Untimely Form 10-K as soon as practicable.

18:01 EDT Avino Silver & Gold Mines reports contractor death at Durango property - Avino Silver & Gold Mines said the company "regrets to report the tragic loss of life of a contractor's employee at the Avino Mine Property in Durango, Mexico." "On behalf of Avino, we extend our sincerest sympathies and support to the families, friends and colleagues of the deceased," stated David Wolfin, President and CEO of Avino. Avino's management and staff are supporting the Mexican authorities with their investigation and currently Avino does not expect the accident to affect production from the Avino Mine.

17:55 EDT Lumentum falls 8% to $46.90 after lowering Q3 revenue outlook

17:23 EDT dMY Technology Group VI going into liquidation - dMY Technology Group VI's Directors made a determination that it would not be in the best interests of those involved to proceed with the combination with Rain Enhancement Technologies. Accordingly, the company intends to dissolve and liquidate in accordance and will redeem all of the shares of Class A Common Stock that were included in the units issued in its initial public offering, at a per-share redemption price payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to dMY VI to pay its taxes - less up to $100K of interest to pay dissolution expenses -, divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders' rights as stockholders. dMY VI is ceasing its efforts and is returning the capital held in the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the shares of Common Stock. Record holders may redeem their shares for their pro rata portion of the proceeds of the trust account. Investors holding through a broker need to take no action in order to receive payment. The redemption of the shares of Common Stock is expected to be completed within ten business days after April 5. There will be no redemption rights or liquidating distributions with respect to the company's warrants, which will expire worthless.

17:12 EDT Raytheon Technologies, Boeing awarded shared $400M Air Force contract - Raytheon Technologies (RTX) and the Boeing (BA), have been awarded a shared $400M ceiling, indefinite-delivery/indefinite-quantity for research and development for the Advanced Aerospace Systems Technology Research program. This contract has multiple awardees to be awarded at different dates. The primary objective of the program is to conduct research toward the development, demonstration, integration, and transition of new aerospace vehicle technologies, designs, and integrated systems that will provide advanced capabilities to the Department of the Air Force. Work will be performed at each contractor facility, unless otherwise indicated in each task order, and is expected to be complete by April 5, 2030. This contract was a competitive acquisition, and 15 offers were received. FY23 research, development, test and evaluation funds in the amount of $200,064 will be distributed among each contractor at time the time of award. Air Force Research Laboratory Wright-Patterson Air Force Base, Ohio, is the contracting activity.

17:05 EDT Disney's largest shareholder, former executive Ike Perlmutter gives statement - The following is a statement by Ike Perlmutter, former chairman of Marvel Entertainment and the largest individual shareholder of The Walt Disney Co. explaining the reason he believes he ended his working relationship with the company on March 29. "I have long expected that my working relationship with Disney would end. That it should come as a result of my trying to help Disney improve its business should sadden many shareholders as it does me, the company's largest individual shareholder. Despite my employment termination, I will continue to hold my shares of Disney and continue to seek improvements at the company for the benefit of all stakeholders. Anyone who knows me is well aware of my fixation on fiscal discipline to improve efficiency. It is that approach to Disney's operations that has formed my support for Trian, in seeking to restore the dividend, fix the company's inflated cost structure, and ensure a successful CEO succession. Trian CEO Nelson Peltz has a long history of improving shareholder returns at many leading consumer businesses. I believe he could have done the same for Disney as a member of its board. It's a disappointment for me and I believe many fellow shareholders that he wasn't welcomed to the board and that it took the threat of a proxy contest for the board and management to begin to act. My ties to Disney are deep and extend more than 30 years. The Marvel brand which I brought to the company in 2009 is now one of the strongest and most profitable business units in the company, as well as one of the best-known entertainment franchises in the world. I wish only the very best for Disney stakeholders - its employees around the world, its millions of devoted fans and customers, its brilliant creators and contributors, and its many shareholders, like me. I will continue to advocate for actions that secure Disney's long-term financial health and allow a new generation of management to reverse the trend of falling shareholder equity and return the dividend to its prior level."

17:00 EDT MarketAxess falls 14% after reporting monthly volume statistics for March and Q1 - Shares of electronic trading platform MarketAxess Holdings closed down 14% or $55 per share on Wednesday to finish the session at $337.74 after the firm announced monthly trading volume and preliminary variable transaction fees per million for the month and the first quarter ended March 31 earlier on Wednesday. The company reported record $296.3B in total credit trading volume; $12.9B in total credit average daily volume, ADV, up 4%. Record U.S. high-grade Open Trading penetration1 of 37% on a 5% increase in U.S. high-grade ADV to $6.1B. Estimated market share of 19.9%. 14% increase in U.S. high-yield ADV to $1.8B with estimated market share of 18.9% , up from 15.1%. Emerging markets ADV of $2.7B down 16%.

16:46 EDT Nike names KeJuan Wilkins as Chief Communications Officer - NIKE "announced a change in its senior executive leadership team. KeJuan Wilkins, Vice President of Enterprise Communications, will become the company's new Executive Vice President, Chief Communications Officer. In his new role, Wilkins will lead all global corporate, consumer, and employee communications for NIKE, Inc. He succeeds Nigel Powell, the company's long-time EVP, Chief Communications Officer, who will retire this summer. As a member of the company's Executive Leadership team, Wilkins will report directly to Donahoe. Wilkins, a 17-year veteran of the company, most recently led corporate and employee communications globally for Nike. He has previously led communications for Nike's North America geography and the Jordan Brand. Before Nike, Wilkins held roles in the athletic footwear industry and with the New York Knicks."

16:38 EDT Costco down 3% afterhours following March sales data - Shares of Costco are down 3% or $14.61 at $482.52 per share after its March total sales data. Costco March total comparable sales data also showed a decline of 1.1% while its e-commerce comp sales were down 12.7% vs. last year.

16:35 EDT International Game expands sports betting footprint to New Mexico - International Game Technology announced that it has expanded its sports betting footprint to New Mexico via a multi-year agreement with the Pueblo of Santa Ana tribe. IGT's award-winning IGT PlaySports platform, self-service betting kiosks, and trading advisory services replaced a competitor's technology and services and are now powering sports betting at Santa Ana Star Casino Hotel in Santa Ana Pueblo. IGT offers a scalable and reliable turnkey sports betting solution that Santa Ana Star Casino Hotel deployed to elevate the performance and appeal of our sportsbook," said John Cirrincione, Santa Ana Star Casino Hotel CEO. "IGT's partnership and proven PlaySports platform enable us to provide our casino patrons with premium sports betting options." "Santa Ana Star Casino Hotel knew that adding sports betting would enhance the gaming experiences available to its patrons when it opened its sportsbook several years ago and we are thrilled that the tribe has decided to upgrade its offering by partnering with IGT," said Joe Asher, IGT President of Sports Betting. "IGT is committed to leveraging our vast experience powering sports betting at tribal casinos and our world-class betting products and services to help Santa Ana Star Casino Hotel achieve maximum sportsbook growth."

16:33 EDT Cboe Global Markets reports March trading volume - Cboe Global Markets reported March monthly trading volume statistics across its global business lines and provided guidance for selected revenue per contract/net revenue capture metrics for the first quarter of 2023. Reference Link

16:30 EDT Dick's Sporting exec Hayes sells 5,000 common shares - In a regulatory filing, Dick's Sporting Goods senior VP and general counsel John Edward Hayes III disclosed the sale of 5,000 common shares of the company on April 3 at a price of $141.50 per share.

16:24 EDT Tattooed Chef receives noncompliance letter from Nasdaq - Tattooed Chef announced that it received a letter on March 31 from Nasdaq informing the company that it was not in compliance with Nasdaq Listing Rule 5250, which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The notification letter has no immediate effect on the listing or trading of the company's common stock on the Nasdaq Capital Market. The company filed a Notification of Late Filing on Form 12b-25 on March 17, 2023, indicating that the filing of the Form 10-K would be delayed since the company implemented a new enterprise resource planning system at one of the company's major subsidiaries, New Mexico Food Distributors and the company's accounting department had been fully occupied with restating its unaudited condensed consolidated financial statements for quarters ended March 31, 2022 and June 30, 2022, and its audited annual consolidated financial statements for the year ended December 31, 2021.

16:20 EDT Fox Factory announces departure of CFO Scott Humphrey - In a regulatory filing earlier, Fox Factory disclosed that on April 5 the company announced the departure of Scott Humphrey, the company's Chief Financial Officer and Treasurer. "Mr. Humphrey's departure was not the result of any disagreement regarding the company's operations, policies or practices," the company stated in its filing.

16:15 EDT LCI Industries names Lillian Etzkorn CFO - LCI Industries announced the appointment of Lillian D. Etzkorn as Executive Vice President and Chief Financial Officer effective April 17, 2023. As previously announced, Brian Hall, LCI Industries' current Executive Vice President and Chief Financial Officer, will retire to pursue philanthropic ventures and opportunities as well as spend more time with his family. Mr. Hall will stay on in an advisory role to ensure a smooth transition. "Lillian has had an esteemed career, solidifying her financial acumen and industrial and manufacturing expertise. In her past roles, she has demonstrated her ability to create positive change and produce results, efficiently aligning internal teams to enhance profitability and cash generation. Lillian's numerous accomplishments give us great confidence in her ability to extend our financial and operational leadership," commented Tracy D. Graham, Chairman of Lippert's Board of Directors. "Throughout our extensive search for Brian's successor, Lillian time and again exhibited the qualities we believe are critical to delivering on the Company's next chapter of growth."

16:10 EDT Acushnet Holdings names Sean Sullivan as new CFO - On April 3, 2023, Sean Sullivan accepted an offer from Acushnet Holdings to become its Executive Vice President and Chief Financial Officer. Mr. Sullivan is expected to be appointed to such position by the Company's board of directors, effective June 1, 2023. In connection with his acceptance of such offer of employment, Mr. Sullivan informed the Company of his intent to resign from the Board, effective June 1, 2023. Thomas Pacheco, the Company's current Executive Vice President, CFO and Chief Accounting Officer, will resign from his position, effective as of June 1, 2023, but will remain with the Company in a transitional role until August 15, 2023.

16:07 EDT Safety Insurance board chairperson David Brussard to retire - Safety Insurance Group announced the retirement of David F. Brussard and the appointments of Charles J. Brophy III and Dennis J. Langwell, effective May 17, 2023, at the upcoming annual meeting of stockholders. With the retirement of Mr. Brussard, the Board of Directors has elected Mr. Murphy to serve as the Chairman of the Board, effective May 17, 2023, in addition to continuing as CEO and President.

15:53 EDT Preliminary North American Class 8 truck orders fell 18% in March, FTR reports - FTR reports preliminary North American Class 8 net orders fell in March for the fifth time in the last six months, coming in at 19,000 units for the month. After rising in February, March orders declined 18% m/m and 11% y/y. While recent orders have softened, order activity is in line with market expectations and running at a robust annualized rate of 340,000 units over the last six months. Class 8 orders have totaled 301,500 units over the last 12 months. With nearly all build slots filled for 2023, slower order activity was anticipated. The reduced order levels will continue through the summer months as we start to enter the normal seasonally weak order period. Fleets continue to request equipment, and quote activity has been in line with past seasonal behavior. Eric Starks commented, "With build activity over the last several months hovering near 27,000 units, backlogs likely fell during the month. Given that backlogs are sitting at such high levels, however, it is difficult to ascertain if there is a fundamental weakening in the Class 8 equipment market given order activity levels. The incoming order rate for March was 228,000 annualized, right in the sweet spot at replacement demand levels. "Overall, the numbers were solid and will have little impact on production levels over the next two quarters. Given the uncertainty in the economy, this is a welcome sign that demand has not collapsed and that fleets still have access to capital." Publicly traded companies in the space include ArcBest (ARCB), J.B. Hunt (JBHT), Knight-Swift (KNX), Old Dominion (ODFL), Swift Transportation (SWFT), Werner (WERN), Navistar (NAV), and Paccar (PCAR). Reference Link

14:43 EDT Lavoro jumps 12% after announcing select 1H results, backs prior projections

13:53 EDT North American rail traffic down 6.3% for the week ending April 1 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending April 1. "Rail volumes today are being negatively influenced by broader economic trends, including slowdowns in industrial output, high inventory levels at many retailers, lower port activity and consumer spending that's not as robust as it was during most of the last three years," said AAR Senior Vice President John T. Gray. "To date, there are no clear economic indicators that suggest this uncertainty will not continue into the immediate future." Total U.S. weekly rail traffic was 467,430 carloads and intermodal units, down 7.4% compared with the same week last year. Total carloads for the week ending April 1 were 233,413 carloads, down 0.4% compared with the same week in 2022, while U.S. weekly intermodal volume was 234,017 containers and trailers, down 13.4% compared to 2022. Four of the 10 carload commodity groups posted an increase compared with the same week in 2022. They included metallic ores and metals, up 2,353 carloads, to 23,440; petroleum and petroleum products, up 1,566 carloads, to 10,127; and motor vehicles and parts, up 1,117 carloads, to 14,874. Commodity groups that posted decreases compared with the same week in 2022 included chemicals, down 1,788 carloads, to 33,347; grain, down 1,657 carloads, to 20,628; and nonmetallic minerals, down 1,331 carloads, to 30,702. North American rail volume for the week ending April 1 on 12 reporting U.S., Canadian and Mexican railroads totaled 341,360 carloads, up 1.8% compared with the same week last year, and 308,322 intermodal units, down 14% compared with last year. Total combined weekly rail traffic in North America was 649,682 carloads and intermodal units, down 6.3%. North American rail volume for the first 13 weeks of 2023 was 8,314,939 carloads and intermodal units, down 3.6% compared with 2022. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Trinity Industries (TRN), Greenbrier (GBX). FreightCar America (RAIL) and Wabtec (WAB). Reference Link

13:35 EDT Nogin, Hawke Media partner for digital marketing, platform technology - Nogin and Hawke Media announced partnership that is expected to revolutionize the digital marketing landscape. This collaboration combines Nogin's intelligent commerce technology with Hawke Media's performance marketing capabilities. The companies said, "The result is an offering that Nogin and Hawke Media believe will drive excellence in both acquisition and retention tactics across channels."

13:23 EDT Energous announces 1W PowerBridge approved by Japan's regulator - Energous announced that its 1W PowerBridge has been approved by Japan's regulatory body for unlimited power distance transmission. "This approval enables Energous to deploy its active energy harvesting technology throughout the technologically advanced Japanese market in smart home, industrial, retail, healthcare IoT applications such as real-time asset tracking and digital supply chain management with no distance limitations. Energous' regulatory approval in Japan is the latest milestone in a series of major market approvals for 1Watt PowerBridge, with similar certifications previously having been obtained in South Korea, China, the United States, Canada, the UK, Europe, India, Australia and New Zealand," the company stated.

13:17 EDT Western Alliance reports Q1 total deposits of $47.6B vs. $53.6B in Q4 - Western Alliance provided additional unaudited financial information and clarifies deposit levels as of March 31. End of quarter total deposits were $47.6B compared to $53.6B as of December 31, 2022; As noted previously, the bank said it experienced elevated net deposit outflows surrounding the announcements of the Silicon Valley Bank and Signature Bank closures in mid-March, concentrated primarily in its Technology and Innovation and Settlement Services groups, with net outflows falling sharply and returning to normalized levels by March 17; Since March 20, deposit balances stabilized and grew approximately $900M to quarter end; Since March 31, quarter-to-date deposit growth has continued this trajectory and increased an additional $1.2B as of April 4; Total insured deposits, including collateralized and pass-through insured deposits, represent approximately 68% of total deposits, "significantly higher than year-end," Western Alliance said. "This increase in the proportion of insured deposits following the elevated outflows in mid-March was driven almost entirely by strong utilization and growth in reciprocal deposits and collateralized deposits for clients," it added.

12:44 EDT Boeing's ForeFlight acquires flight debriefing software provider CloudAhoy - ForeFlight, a Boeing Company, has acquired CloudAhoy, a company that provides post-flight debriefing, analytics, and flight operations quality assurance software products for flight training, as well as business, general and military aviation pilots and operators. The companies are not disclosing any terms of the transaction. "CloudAhoy's advanced capabilities and products will complement and integrate nicely into our existing digital portfolio, and we are excited for CloudAhoy and its employees to join our team," said Tim Schuetze, ForeFlight CEO. "Recording and debriefing flights has been a staple of ForeFlight for years, and CloudAhoy's software will enable even deeper post-flight analysis of every flight."Reference Link

12:06 EDT TOP Financial Group Ltd trading halted, volatility trading pause

12:00 EDT C3.ai falls -11.9% - C3.ai is down -11.9%, or -$2.98 to $21.98.

12:00 EDT Gold Fields rises 4.1% - Gold Fields is up 4.1%, or 58c to $14.56.

12:00 EDT Direxion Daily Semiconductor Bear 3X Shares rises 7.3% - Direxion Daily Semiconductor Bear 3X Shares is up 7.3%, or $1.29 to $18.99.

11:34 EDT Fresh Vine adds 2,037 new points-of-distribution in Q1 - Fresh Vine Wine reported that distributor depletions in the first quarter of 2023 improved by 58% from the same year ago quarter. In the first quarter of 2023, Fresh Vine added 2,037 new Points-of-Distribution, increasing its footprint by almost a third. Rick Nechio, Interim CEO said, "The new year is off to a great start, led by a significant expansion and growing momentum in the retail channel. In the first quarter of 2023, this strong momentum led to a 58% improvement in distributor depletions* to replenish the approximately 8,000 cases of wine that consumers pulled off retail shelves in the first quarter. Based on Nielsen Scan Data, retailer sales of Fresh Vine Wine in the 52 weeks ending 2/13/2023 have increased 4-fold from the comparable year ago period, or an increase of 40,874 bottles scanned at retailer registers."

11:13 EDT ShotSpotter down 25%, on track for record daily drop - Shares of ShotSpotter are down $9.53, or 25%, to $28.35. Data from Down Jones and FactSet show that if the current decline holds, it would be the stock's largest percent decrease on record based on available data back to June 7, 2017.

10:54 EDT Zscaler down 7% in morning trading - Shares of Zscaler are down $7.87, or 7%, to $102.64 in morning trading. Earlier, Cleveland Research had published a note which said its checks returned "cautious" feedback on large deal traction with sales cycles lengthening.

10:01 EDT Select Medical agrees to acquire Vibra Hospital of Richmond - Select Medical announced it has signed an agreement to acquire Vibra Hospital of Richmond, a long-term acute care hospital in Richmond, Virginia. Financial terms of the deal were not disclosed. "We look forward to bringing the industry's highest quality of critical illness recovery care to Richmond as the needs for this patient population continue to grow across the region. The acquisition will also extend Select Medical's care continuum in Virginia providing access to a full network of inpatient and outpatient care settings throughout a patient's recovery journey," said Tom Mullin, executive vice president of hospital operations at Select Medical.

10:00 EDT ZIM Integrated falls -7.7% - ZIM Integrated is down -7.7%, or -$1.51 to $18.03.

10:00 EDT AngloGold Ashanti rises 4.4% - AngloGold Ashanti is up 4.4%, or $1.12 to $26.50.

10:00 EDT Harmony Gold rises 6.4% - Harmony Gold is up 6.4%, or 28c to $4.63.

09:47 EDT Natura &Co falls -7.0% - Natura &Co is down -7.0%, or -37c to $4.88.

09:47 EDT Western Alliance falls -8.8% - Western Alliance is down -8.8%, or -$2.94 to $30.58.

09:47 EDT Harmony Gold rises 4.4% - Harmony Gold is up 4.4%, or 19c to $4.54.

09:41 EDT Meta names Evelyn Aswad as Oversight Board co-chair - Meta provided an update on its Oversight Board membership: "We are announcing that 17 Board Members appointed in 2020, including our three Co-Chairs, have been renewed for a second term, which began on April 1, 2023. Other Members who joined the Board later will be eligible for renewal at the end of their first terms. With the completion of Board Members' first terms, Meta is withdrawing from the selection process. Once the ongoing processes for selecting two new Board Members are complete, the Oversight Board will be solely responsible for the selection of all future Board Members.... The departure of Jamal Greene in January 2023 left a vacant post among the Oversight Board Co-Chairs. Today, we are announcing that current Board Member Evelyn Aswad has been appointed to serve as a Co-Chair. Evelyn was appointed by our existing Co-Chairs Catalina Botero-Marino, Michael McConnell, and Helle Thorning-Schmidt, with support from Board Members. Meta was not involved in Evelyn's appointment." Meta also announced that original Board member Maina Kiai has decided to step down from the Board to focus on other projects. Reference Link

09:33 EDT Stellantis says all-electric 2025 Ram 1500 REV to have 'unsurpassed' range - The all-new, all-electric 2025 Ram 1500 REV - the first battery-electric light-duty pickup truck from Ram Truck - makes its world debut today at the New York International Auto Show, announced Stellantis. "The 2025 Ram 1500 REV will offer customers two all-electric options, including a standard 168-kilowatt-hour battery pack with a targeted range of up to 350 miles and an optional 229-kWh large battery pack with a targeted range of up to an unsurpassed 500 miles. Both can add up to 110 miles of range in approximately 10 minutes with 800-volt DC fast charging at up to 350 kW, offering customers quick and convenient charging solutions. Vehicle-to-vehicle, vehicle-to-home and vehicle-to-grid bi-directional charging affords the Ram 1500 REV the flexibility to charge another Stellantis battery-electric vehicle or provide power back to the grid. With Ram's mission to make lives easier, the truck can also send power to a home during a storm, run the tailgate party or provide power at the camp or jobsite. An onboard power panel in the bed can provide up to 7.2 kW while an available onboard power panel in the front trunk provides up to 3.6 kW," the company stated.

09:31 EDT VirnetX partners with WeSecure to sell cybersecurity products - VirnetX and WeSecure are proud to announce a non-exclusive commercial agreement for WeSecure to sell VirnetX cybersecurity products in the U.S., Canada and the Middle East. The partnership aims to implement VirnetX's advanced security technologies into WeSecure's Physical and CyberSecure products and services.

09:22 EDT Micromobility.com announces Share Intel identified consistent trading imbalances - micromobillity.com announced that Share Intel's extensive analysis of MCOM stock has identified consistent imbalances and reported short interest, signaling the potential presence of illegal naked short sales. When compared to the average trading volume, these imbalances prove to be notably significant. The uncovered discrepancies may represent only the "tip of the iceberg," with the possibility of more extensive issues concealed within dark pools and ex-clearing activities.

09:19 EDT Euroseas announces new charter for container vessel M/V Synergy Keelung - Euroseas announced a new charter of its container vessel M/V "Synergy Keelung." Specifically: M/V "Synergy Keelung", a 4,253 TEU vessel built in 2009, entered into a new time charter contract for a period of between a minimum of twenty-four and a maximum of twenty-six months at the option of the charterer, at a gross daily rate of $23,000. The new charter will commence in April 2023 immediately following the completion of its current charter. Aristides Pittas, Chairman and CEO of Euroseas commented: "We are pleased to announce the new charter of our vessel M/V Synergy Keelung with a first-class charterer. We believe that both the rate and, especially, the duration of the charter are indicative of the resilience of the containership market which has firmed up after the adjustment that took place over the last six months. M/V Synergy Keelung's charter will generate about $10m of EBITDA over the next two years providing a higher contribution to our earnings per share than previously expected."

09:18 EDT Surna, CEA Industries' subsidiary sign contract to provide services - Surna Cultivation Technologies and a subsidiary of CEA Industries announced that it has signed a contract valued at $335,400 to provide architectural and engineering design services to a cannabis cultivator located in the Southeastern United States. Under the contract, Surna has been commissioned to provide design services for a 60,0000 sq. ft. cannabis cultivation facility and a 20,000 sq. ft. processing facility that are parts of a larger operation including greenhouse production and retail. Surna's services will include a full architectural design package and MEP engineering. Valued at over three hundred thousand dollars, the agreement marks the single largest design contract in the Company's history. Construction is expected to be completed in 2023. CEA Industries Inc. CEO Tony McDonald added "I am very proud of our team for winning this substantial contract in the midst of a difficult time in the CEA industry. This project demonstrates that quality projects continue to be developed to serve the long-term growth of the industry."

09:14 EDT Hudbay Minerals' Copper World project receives permitting update - Hudbay Minerals received confirmation from the Army Corps of Engineers, ACOE, that Hudbay's previous surrender of the Section 404 Clean Water Act permit for the former Rosemont project was formally accepted and revoked as requested. The ACOE also reaffirmed the validity of the March 2021 approved jurisdictional determinations whereby the ACOE determined there are no waters of the U.S. on the property, and therefore, a 404 Permit is not required. State permitting for the Copper World project was initiated in June 2021 with the submission of Hudbay's Mined Land Reclamation Plan, which has been approved.In late 2022, Hudbay submitted the state-level applications for an Aquifer Protection Permit and an Air Quality Permit to the Arizona Department of Environmental Quality. Hudbay continues to expect to receive these two remaining state permits in 2023. In January 2023, Hudbay received an approved right-of-way from the Arizona State Land Department that will allow for infrastructure, such as roads, pipelines and powerlines, to connect between the properties in the company's private land package at Copper World. Clearing and grading work to prepare for the Copper World site, including the construction of roads and other facilities, continues to be underway. Phase I of Copper World reflects a 16-year standalone operation with processing infrastructure on Hudbay's private lands and mining occurring on patented mining claims, requiring only state and local permits. Hudbay also intends to initiate a minority joint venture partner process following receipt of permits, which will allow the potential joint venture partner to participate in the design and funding of definitive feasibility study activities in 2024.

09:13 EDT AGBA Acquisition to acquire Sony Life Financial Advisors, terms not disclosed - AGBA Group Holding announced that it has entered into a sale and purchase agreement, dated 5 April 2023, to acquire Sony Life Financial Advisers Pte Ltd, a duly licensed financial adviser and insurance broker in Singapore. The company said, "The latest acquisition marks a key milestone for AGBA; it is lucrative to its insurance and fintech businesses and expands access to key markets in Asia. While AGBA's primary focus is in the Greater Bay Area in China, Singapore was selected for expansion due to the island nation's position and reputation as a global center for innovation, business and finance. Ranked 10th place for average income by country, Singapore has is known to have one of the highest saving rates in the world."

09:10 EDT epay launches Skylight financial transaction monitoring platform - epay announced the launch of Skylight, a new platform that brings much-needed innovation to the complex and tedious manual work compliance analysts face when maintaining compliance programs for regulated financial transactions at money services businesses such as retailers, digital banks and fintechs. A cloud-based platform available on the Microsoft Azure and AWS marketplaces, Skylight enhances compliance analysts' productivity levels through analytics to identify the highest priority compliance issues while reducing the "false positives" that consume time and resources unnecessarily. When suspicious transactions are identified, Skylight triggers alerts for compliance analysts and then streamlines follow-up tasks such as one-click Suspicious Activity Report submissions to FinCEN, the Financial Crimes Enforcement Network of the United States Department of the Treasury.

09:09 EDT Avalon Acquisition confirms funding to extend business combination period - Avalon Acquisition announced today that The Beneficient Company Group deposited an aggregate of $2,070,000 into the Company's trust account for the Company's public stockholders, representing $0.10 per public share, which enables us to extend the period of time we have to consummate our initial business combination by three months from April 8, 2023 to July 8, 2022. The Second Extension is the second of up to two three-month extensions permitted under the Company's governing documents. We also received notice from our sponsor that our sponsor intends to effect the Second Extension, and our Board of Directors approved such Second Extension. As previously announced, on September 21, 2022, the Company, BCG, Beneficient Merger Sub I, Inc., and Beneficient Merger Sub II, LLC, entered into a business combination agreement

09:08 EDT Brooge Energy completes technical study for Green Ammonia plant - Brooge Energy (BROG) announced that the technical study of its Green Hydrogen and Green Ammonia plant conducted by thyssenkrupp Uhde (TKAMY) has been completed and delivered. On September 21, 2022, Brooge Energy announced that it engaged thyssenkrupp to undertake a Technical Concept Study and cost estimate for the proposed green ammonia plant, which is based on thyssenkrupp nucera's alkaline water electrolysis and thyssenkrupp Uhde ammonia synthesis technologies. The plant is planned in two phases up to a total of 1950 mtpd export focused green ammonia production facility located in Abu Dhabi in the United Arab Emirates. The plant will produce green ammonia using green hydrogen from solar energy with water and air as raw materials. The study involved a comprehensive techno-economic analysis of the power-to-ammonia value chain using thyssenkrupp's proprietary modeling tool. The goal was to evaluate the influence of various factors on the overall cost-effectiveness of the green ammonia plant. This analysis explored multiple scenarios to identify optimal plant designs coming along with various supporting documentation dealing with technical and execution concepts on a fully integrated approach.

09:06 EDT Brera Holdings launches Media Division - Brera announced the launch of its Media Division, focused on the production and distribution of proprietary multi-platform online and offline content, along with engaging, branded live events that involve public figures linked to the club. Brera FC Media Division content will include live streaming and highlights of Brera-branded and -owned club matches, exclusive web series, limited edition books through an internal print publishing house, podcasts, eSports matches, digital artwork and upcoming digital assets, including NFTs. "The opening of the Brera FC Media Division allows numerous activities of the club to be conveyed in engaging, digital storytelling. The global vision of Brera Holdings, with what we expect to be an increasing number of worldwide clubs in our portfolio, provides continuous content, brand and digital asset ideas and initiatives to be developed," said Sergio Scalpelli, CEO of Brera Holdings.

09:05 EDT Cano Health names Kent as Chief Strategy Officer - Cano Health announced a new appointment to its leadership team to strengthen operations and drive new opportunities for profitable growth. Mark Kent, as the new Chief Strategy Officer, will lead strategy development, spearhead operational initiatives, and consolidate oversight of key administrative supporting functions including contracting, billing and coding, credentialing, payor relations, and information technology that previously reported to other positions, which will not be replaced. Prior to joining Cano Health, Kent founded three startup healthcare companies which help provider practices operate successfully within value-based arrangements: Care Management Resources, Total Health Medical Centers and Your Partners in Health.

09:04 EDT Virpax Pharmaceuticals provides update on Envelta development program - Virpax Pharmaceuticals announced recent progress made in its Envelta development program. Envelta is the company's non-opioid pain product candidate for acute and chronic pain that is being funded under an in-kind grant from the National Center for Advancing Translational Sciences, or NCATS, part of the National Institutes of Health, or NIH. Dose ranging studies for Envelta in both rats and dogs were recently completed, and the intranasal administration of Envelta was well-tolerated and no adverse effects were observed. The data from these studies will be used in Virpax's Investigational New Drug, or IND, application to the FDA as well as to establish safe dosing for the first-in-human trials of Envelta.

09:03 EDT SenesTech announces distribution agreement with Target Specialty Products - SenesTech announced a national distribution agreement with Target Specialty Products for ContraPest. In addition to distribution, Target Specialty Products and SenesTech will be actively collaborating in marketing and selling ContraPest throughout its network.

09:02 EDT Y-mAbs Therapeutics announces first patient dosed in Phase 1 trial of GD2-SADA - Y-mAbs Therapeutics announced that the first patient has been dosed with both the protein dose and the 177Lu-DOTA imaging dose in its Phase 1 clinical trial, evaluating the Company's pre-targeted radioimmunotherapy Self-Assembly and Disassembly-Bispecific, SADA, technology platform for the treatment of certain GD2-positive solid tumors, including small cell lung cancer, sarcoma and malignant melanoma. The two-step approach separating the administration of SADA protein from the administration of radioactive ligand is believed to differentiate SADA constructs from most other radioimmunotherapy approaches. "We are excited to advance our SADA platform into the clinic for the first time with the initiation of patient dosing in this trial. This is a significant milestone for Y-mAbs in our efforts to potentially build a global franchise of radiotherapeutic assets," said Thomas Gad, Founder, President, and Interim CEO. "SADA can potentially generate the clinical data to further unlock the potential of radiolabeled therapeutics in tumors that have not historically demonstrated meaningful responses. Further, during the first part of the study, Part A, we plan to collect imaging data to assess tumor targeting and assess the PK profile of GD2-SADA, as this could potentially allow for early evaluation of the program and more informed development decisions."

09:01 EDT PLBY Group announces it sold Yandy Enterprises for $3M - PLBY Group announced that it has sold its Yandy Enterprises subsidiary for $3M. The sale is a part of the PLBY Group's transition to a capital light model that will focus on the Company's most valuable brands, Playboy and Honey Birdette.

08:52 EDT Nuburu selected by DoD as part of $75M multiple award IDIQ for HEL systems - Nuburu (BURU) announced that it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite Delivery/Indefinite Quantity contract for the fabrication and delivery of prototypes and equipment in support of solid-state high energy laser weapon systems. "NUBURU has the ability to manufacture laser diode, fiber optic and optical subsystems in the U.S. making us well positioned to support the DOD with its needs regarding this critical next-generation national security issue," said Dr. Mark Zediker, CEO and Co-Founder of NUBURU. "We are proud to use our automated manufacturing capabilities and a workforce entirely based in the U.S. to provide high-power laser subsystems for our customers." As one of seven companies selected, NUBURU is eligible to participate in the firm-fixed-price, indefinite-delivery/indefinite-quantity, multiple award contract with a maximum ceiling of $75M. The other selected companies include divisions of Rolls-Royce, General Atomics, Dynetics, II-VI, Lockheed Martin (LMT), and nLIGHT. The location percentages are currently unknown and will be determined at the delivery order level. Work is expected to be completed by March 2028. The Naval NUBURU has not included any potential revenue from this new contracting vehicle in the 2023 forecast that it released on March 21.

08:50 EDT Walmart 'comfortable' with current price gaps to the market

08:40 EDT ShiftPixy expands on how 'Fast Fill Technology' works to solve labor shortages - ShiftPixy expanded on how its Fast Fill technology works. Designed to meet the needs of the modern workforce, by leveraging the power of mobile devices ShiftPixy is able to connect with the new part-time workers where they are - on their smartphones. In a statement the company said, "In today's world of work, businesses dependent on part-time labor are facing a major "people problem" - they can't seem to find enough workers. Traditional methods of attracting and retaining employees have lost efficacy, and employers are struggling to adapt on their own to the changing job market landscape. According to studies, 94% of consumers look for local information on their smartphones, and 90% of those audiences take action as a result. This is where today's part-time worker lives and is fully engaged. By meeting workers where they are, ShiftPixy is at their fingertips and uniquely adapted to filter part-time opportunities directly to this workforce, introducing them to suitable work opportunities and moving them through a start-work process that is simple, personal, and friction-free." "Today's part-time worker is smartphone addicted, and we understand that to solve the new 'people problem' we need to meet them where they are," said Scott Absher, Co-Founder and CEO of ShiftPixy. "The ShiftPixy Fast Fill technology allows us to do just that, and we are excited to bring this innovative solution to our clients. ShiftPixy's Fast Fill technology streamlines the process of finding, hiring and onboarding the right candidates, allowing businesses to focus on growing their bottom line." "Traditional methods of attracting and retaining employees are no longer effective," continued Absher. "If you are trying to solve the new people problem with the same old tools, you will be disappointed. ShiftPixy's Fast Fill technology offers a solution that is innovative, effective, and meets the needs of the modern workforce."

08:38 EDT Rexford Industrial acquires three industrial properties for $357.2M - Rexford Industrial Realty announced three industrial property acquisitions for an aggregate purchase price of $357.2M. The Company also announced the disposition of one property for $17.0M. The acquisitions were funded using a combination of cash on hand, proceeds from forward equity settlements and the Company's recent public bond offering. Howard Schwimmer and Michael Frankel, Co-CEO, said, "As the nation's largest pure-play, U.S. focused industrial REIT, Rexford Industrial is well-positioned to drive accretive internal cash flow growth as we roll our substantially below-market leases to higher market rents and through the lease-up of our repositioning and redevelopment projects currently in-process. In addition, with approximately 2% market share within the highly-fragmented infill Southern California industrial market and with a near-term investment pipeline of over $125M of acquisitions under contract or accepted offer, the Company continues to leverage its local, sharp-shooter advantage to expand our infill Southern California industrial property portfolio in a highly accretive manner. Bolstered by our low-leverage, best-in-class balance sheet, the Company is favorably positioned to deliver long-term value creation for our shareholders." The Company acquired: 3520 Challenger Street, Torrance, located in the LA - South Bay submarket for $14.2M; 9000 Airport Boulevard, Los Angeles, located in the LA - South Bay submarket for $143.0M; 9223 and 9323 Balboa Avenue and 4285 Ponderosa Avenue, San Diego, located in the Central San Diego submarket for $200.0M. In March, the Company disposed 8101-8117 Orion Avenue, Van Nuys, located in the Greater San Fernando Valley submarket for $17.0M.

08:36 EDT Skyward Specialty Insurance announces leadership changes - Skyward Specialty Insurance has announced leadership changes as the Company takes action to further invest in its Captives and Programs divisions. Ryan Burke will lead the Programs division following his promotion to Vice President, Specialty Programs. Burke joined the Company in 2021 as underwriting manager. The Company also promoted Amy Klatt to Senior Vice President, Captives and Programs Claims. Klatt joined Skyward Specialty in 2019.

08:36 EDT Cenntro Electric, EAVX to collaborate on all-electric and vocational work - Cenntro Electric and EAVX announced that they will collaborate to develop all-electric last mile and vocational work truck solutions. The joint development effort will focus on integration of the commercial truck bodies from JBPCO business units including last mile, service and utility, and vehicle cargo management systems with Cenntro's All-Electric LS300 and LS400 cab chassis.

08:35 EDT Icahn issues new letter to Illumina holders, calls for deSouza to be dismissed - Carl Icahn issued the latest in a series of open letters to Illumina shareholders, in which the investor states in part: "We are not surprised by Monday's events. First, the FTC has joined the EU by deciding to block and force the unwind of Illumina's acquisition of GRAIL. Second, Illumina's directors and CEO Francis deSouza have decided to continue their long history of appealing (and appealing again) in the hope of one day, at great expense, winning an almost impossible battle. Our major concern as a large shareholder is that this multi-year battle will consume hordes of cash and go on for years, luxuries that Illumina does not have. Even in the best case for Mr. deSouza, the ability to own GRAIL will be a pyrrhic victory, as the core business deteriorates, and customers defect to rival sequencing platforms. In the last few years, CEO Francis deSouza has allowed our potentially great company to deteriorate. He has forced out many of Illumina's talented employees. He has handpicked members of his board, who he believed would blindly follow him and overlook the fact that he knew very little about the genetics industry, while removing those who were a threat to his longevity. Illumina's revenue growth has deteriorated a staggering 90% during his tenure at the company. His shareholder-funded GRAIL adventure is a desperate 'Hail Mary' power grab to attempt to reverse the declining fortunes of Illumina. It is his second major M&A failure since he has led Illumina. Not only has this folly cost the shareholders $50 billion in value but it should be realized that Illumina does not have the financial wherewithal to continue this fight. Do not be fooled when Mr. deSouza says that this will be a short battle. We believe the board of directors should dismiss Mr. deSouza immediately and bring back Jay Flatley (or someone else on his level) as CEO. And most importantly, for the sake of both Illumina and GRAIL, these companies should be separated immediately to protect the long term growth prospects and viability of each entity." Reference Link

08:33 EDT Nano Dimension prepared to commence tender offer to acquire Stratasys - Nano Dimension (NNDM) is prepared to commence a special tender offer targeting total ownership of at least 51% of the outstanding shares of common stock of Stratasys Ltd. (SSYS) for $18.00 per share in cash, inclusive of the approximately 14.5% of Stratasys' outstanding common shares that Nano Dimension currently owns. Nano Dimension remains willing to negotiate in good faith a consensual transaction at its previously announced "best and final" offer of $20.05 per share, subject to receiving necessary diligence. However, in the event the Stratasys Board of Directors continues its unwillingness to engage with Nano Dimension, the Company is prepared to commence this special tender offer. Nano Dimension's all-cash special tender offer would represent a premium of 26% to the closing trading price as of March 3rd, 2023, a 29% premium to the Company's 30-day VWAP, a 39% premium to the 60-day VWAP and a 35% premium to the 90-day VWAP as of March 3rd, 2023. In addition, Nano Dimension intends to seek relief from an Israeli court confirming that according to Israeli Companies Law, Stratasys' poison pill cannot be triggered in response to a special tender offer targeting Nano Dimension's ownership of at least 51% of Stratasys' outstanding shares. Both paths that are discussed above, will deliver immediate and certain value at a compelling premium to Stratasys shareholders and enables the Company to create the preeminent leader in the rapidly growing AM market. Nano Dimension will provide additional details and timing of the special tender offer in due course and as required by applicable law.

08:33 EDT Lipella doses first patient in clinical study of new bladder MRI contrast agent - Lipella Pharmaceuticals announces it has dosed the first patient in its human clinical study of a novel bladder MRI contrast agent. Lipella's contrast agent is composed of two MRI contrast agents and is expected to be useful for the diagnosis of interstitial cystitis/bladder pain syndrome, or IC/BPS,) and potentially other bladder diseases characterized by bladder wall defects. Lipella believes the agent may also have utility in detecting bladder tumor progression to muscle-invasive bladder cancer. The study is being funded by a $1.35M Small Business Innovation Research, or SBIR, Phase II grant awarded to Lipella by the National Institute of Diabetes and Digestive and Kidney Diseases, or NIDDK, in 2022. The two-year grant will support the clinical development of intravesical contrast-enhanced magnetic resonance imaging (ICE-MRI) technology, and is expected to accelerate clinical development of ICE-MRI, which could lead to important clinical results.

08:33 EDT Walmart targeting annual increase in ROI, says CFO

08:32 EDT Walmart sees 'inflection point' for returns after CapEx increase, says CFO - Comments taken from the 2023 Investment Community Meeting.

08:32 EDT Caesars relaunches Tropicana Online Casino in New Jersey - Caesars announced the relaunch of Tropicana Online Casino in the state of New Jersey. The new iCasino app and online casino experience offers customers enhanced functionality with a catalog of industry-leading casino games and an improved integration with the industry-leading loyalty program, Caesars Rewards.

08:23 EDT Exelixis holder Farallon issues letter on nominees for director candidates - Funds managed by Farallon Capital Management own approximately 7.2% of the outstanding shares of Exelixis "making us the Company's largest active shareholder. We have been continuously invested in Exelixis since 2018 and believe that the cabozantinib franchise and related intellectual property are durable, and the opportunity to commercialize zanzalintinib is underestimated by many investors. There can be no doubt, however, that Exelixis has been a disappointment for shareholders. Despite starting with a library of promising compounds and eventually commercializing a front-line cancer medicine that generates more than $2B in annual revenue, Exelixis has made essentially no money for its investors. Since its IPO nearly 23 years ago, Exelixis has generated a total shareholder return of less than 1% per year. Most of you have been on this Board long enough - your average tenure is 16 years - to have observed the Company's stagnation. It is time to ask yourselves: what needs to change so that Exelixis finally creates value for shareholders? We believe the Company must focus its R&D efforts and spending, communicate a differentiated and coherent strategy, commit to ongoing distributions of excess capital to shareholders and augment the Board with new perspectives. This is why we recently provided you notice that we intend to nominate three exceptional director candidates to the Board. We believe it is time for change," said Farallon in part in its letter.

08:12 EDT 9 Meters Biopharma plans to submit NM-136 IND to FDA in 2H23 - 9 Meters Biopharma announced receipt of a written response from the U.S. Food and Drug Administration on the request for a Type B pre-IND meeting on the planned pre-clinical development of NM-136 for the treatment of obesity. Based on the response, the Company currently plans to submit an IND to the FDA for this indication in the second half of 2023 based on the completion of the preclinical program. An approved IND is a prerequisite for conducting Phase 1 clinical studies of NM-136 in the U.S.

08:11 EDT WSP Global to acquire Calibre Professionals Services for A$275M - WSP Global entered into an agreement to acquire Calibre Professionals Services One Pty Ltd. Building on the acquisition of Golder in 2021, and in alignment with the Corporation's 2022-2024 strategic action plan objectives, the transaction will enable WSP to further develop its leadership position in Australia as well as support major mining clients who are currently on a path to decarbonize their operations and infrastructure. Calibre is an engineering services provider across the full asset life cycle, focused on rail, infrastructure, rehabilitation, and renewable projects supporting blue-chip mining clients. With a workforce of approximately 800 professionals, Calibre has offices in Perth, Sydney, Melbourne, and Brisbane. The addition of Calibre and its mining advisory and consulting expertise will position WSP to seize significant opportunities related to mine closure and rehabilitation as well as water management. The combined platform will represent over 6,000 professionals across Australia, including over 1,000 experts in the resource sector, and significantly increase WSP's presence in the Pilbara region and Western Australia. The transaction is expected to close in the second quarter of 2023 and is subject to customary closing conditions, including obtaining approval from the Foreign Investment Review Board in Australia. WSP is acquiring Calibre for an aggregate consideration of A$275M, payable upon closing of the acquisition.

08:09 EDT CIIG Capital Partners II intends to adjourn special meeting - CIIG Capital Partners II announced that it intends to adjourn, without conducting any business, the special meeting of its stockholders to be held with respect to the adoption and approval of the definitive merger agreement, dated November 22, 2022, by and among CIIG II, Zapp Electric Vehicles and the other parties thereto, which is scheduled to occur at 12:00 p.m., Eastern time, on April 12, 2023, and to reconvene the Special Meeting at 11:00 a.m., Eastern time, on April 14, 2023. The Special Meeting will be held in person at the offices of Orrick, Herrington & Sutcliffe LLP, located at 51 West 52nd Street, New York, New York 10019. In connection with the adjournment of the Special Meeting, the Company is extending the deadline for holders of its shares of Class A common stock to exercise their right to redeem their shares for their pro rata portion of the funds available in the Company's trust account, or to withdraw any previously delivered demand for redemption, to 5:00 p.m., Eastern time, on April 12, 2023.

08:07 EDT Axcelis announces shipment of its 500th Purion ion implanter system - Axcelis Technologies announced the shipment of its 500th Purion ion implanter system. The shipment went to a leading semiconductor device maker located in North America. The Purion platform is designed to solve customers' high value, high impact, ion implantation challenges.

08:06 EDT Near Intelligence signs renewal deal with its largest European customer - Near Intelligence announced that it signed an eight-figure renewal deal with its largest retail customer in Europe, an increase of approximately 100% over the previous year. By renewing its contract for another term, this European retail chain, which operates multiple brands across several European countries, will continue to use Near's solutions to drive footfall traffic to stores and to measure the effectiveness around those activities; the retailer plans to expand the use of Near across its seven other retail brands. The company's data intelligence insights allow the retailer to get a better understanding of the right catchment area at the store level and deliver appropriate messaging to their prospects and customers.

08:06 EDT Two large stockholders of RumbleON send letter to fellow stockholders - William Coulter and Mark Tkach, who together own approximately 32.2% of the outstanding Class B shares of common stock of RumbleOn announced to fellow stockholders that they have filed a preliminary proxy statement to elect four highly qualified candidates to the Board of Directors of the Company at its 2023 Annual Meeting of Stockholders. The Company has not yet set a date for the meeting. The letter ended "We look forward to engaging with our fellow stockholders and the Board to move RumbleOn in the right direction. We are enthusiastic about the opportunity to improve RumbleOn's operational performance and restore stockholder value. We have no confidence that this will occur at the hands of the existing leadership of RumbleOn."

08:06 EDT Trinseo announces sale of Mexico manufacturing facility to Plaskolite, no terms - Trinseo announced that it has signed an agreement to sell its land, buildings and equipment in Matamoros, Mexico to Plaskolite.The transaction is expected to close within the next several weeks. In December 2022, Trinseo announced the consolidation of some of its PMMA sheet products from the Matamoros site into its continuous sheet manufacturing operations in Florence, Kentucky as part of the company's asset restructuring initiatives. Plaskolite will not acquire any portion of Trinseo's sheet business. "The consolidation of our sheet manufacturing business helps us optimize our resources and continue to deliver on our transformation strategy," said Trinseo President and CEO Frank Bozich. "Our sale of the Matamoros assets to Plaskolite will provide an opportunity for the plant to continue to operate and provide jobs for the Matamoros community." The Matamoros plant is located on nearly 11 acres in Matamoros City in the State of Tamaulipas, Mexico.

08:04 EDT T2 Biosystems announces webinar, white paper highlighting T2Candida Panel - T2 Biosystems announced the availability of a new webinar and white paper highlighting the T2Candida Panel clinical data and best practices from real world use within Medical Intensive Care Units, MICU. The webinar, "Lessons for Diagnosing & Managing Candidiasis in Critically Ill Patients" by Dr. Cornelius Clancy, reviews the T2Candida Panel clinical data and details the implementation process of the T2Candida Panel for patients with septic shock within a MICU. In the webinar, Dr. Clancy notes that the five targets on the T2Candida Panel account for 95% of invasive candidiasis infections at most centers. He outlines the treatment algorithm and outcome data in the MICU including: T2Candida Panel significantly shortened time to diagnosis and time to antifungal treatment; T2Candida Panel decreased the duration of antifungal therapy as negatives supported the reduction of antifungal therapy.

08:03 EDT Pioneer Power announces contract for a 75KW e-Boost Mobile - Pioneer Power Solutions announced that a major northeastern transportation agency that manages air, land, rail and sea assets has contracted with the Company to secure a 75KW e-Boost Mobile. This unit was delivered with a fast-charging direct-current charger as well as multiple standard Level 2 chargers on board, providing charging options for multiple vehicles. The customer has entered into a long-term rental agreement for the e-Boost system to charge multiple EV shuttle buses, and other EV vehicles at several operating facilities. The unit was delivered during the Q1, and is already deployed.

08:03 EDT Equinix announces new data center in Montreal - Equinix announced a new state-of-the-art International Business Exchange data center in Montreal. The new facility is expected to open in the second half of 2023. Known as MT2, the new site will expand Equinix's presence in Montreal and continue the company's commitment to bring the full value of Platform Equinix and its portfolio of solutions to Canadian businesses. Montreal is a key economic center in Canada and globally, as well as a major innovation hub with one of the largest concentrations of technology workforces in Canada.

08:01 EDT Fulcrum Therapeutics announces CFO resignation - Fulcrum Therapeutics announced that Esther Rajavelu has resigned from her position as chief financial officer, CFO, and treasurer effective April 21, 2023. Rajavelu will serve in a consulting role to ensure the continuity of Fulcrum's financial operations.

08:01 EDT Western Alliance down 6% at $31.50 after quarter-end financial update

07:58 EDT Aeterna Zentaris says sales of Macrilen to be temporarily discontinued in U.S. - Aeterna Zentaris (AEZS) announced that sales of Macrilen will be temporarily discontinued in the United States commercial market for the diagnosis of adult growth hormone deficiency, effective May 23, 2023 and until anticipated re-launch with an alternate commercialization partner. This temporary action follows the August 29, 2022 announced decision by Aeterna's former North American commercialization partner Novo Nordisk Healthcare (NVO) to end its license agreement for this product in North America. The Company is actively seeking alternate development and commercialization partners for Macrilen in the US and other territories currently not partnered. The decision to temporarily discontinue sales of Macrilen in the United States does not have any impact on the sales and commercialization efforts in the UK and European Economic Area. On March 16, 2023, Aeterna announced that Pharmanovia, a global lifecycle management healthcare company, had acquired the exclusive rights and license to commercialize GHRYVELIN in the territory for the diagnosis of Adult Growth Hormone Deficiency and, if approved, for Childhood Onset Growth Hormone Deficiency from the Company's previous EEA and UK partner, Consilient Health.

07:49 EDT FedEx increases 2024 dividend 10% to $5.04 per share - The FedEx board of directors approved an increase in the annual dividend rate on its common stock of 10%, or 44c per share, to $5.04 per share for fiscal 2024. The board declared a quarterly cash dividend of $1.26 per share of FedEx common stock. The dividend is payable July 3, 2023 to stockholders of record at the close of business on June 12, 2023.

07:39 EDT FedEx expects DRIVE transformation to generate $4B of cost reductions in FY25 - The DRIVE transformation spans 14 domains across four major areas: Customer, Surface Network, Air Network & International, and General and Administrative. FedEx expects DRIVE to generate $4B of permanent cost reductions in fiscal 2025. Each area is expected to generate savings in fiscal 2025 as follows: $1.2B in Surface Network, $1.3B in Air Network & International and $1.5B in General & Administrative. DRIVE is also enabling the implementation of Network 2.0, which is expected to generate an incremental $2B of savings in FY27. FedEx continues to project costs of up to $2B by the end of fiscal 2025 to implement its business optimization initiatives including the DRIVE and Network 2.0 programs. Additionally, the FedEx board of directors approved an increase in the annual dividend rate on its common stock of 10%, or 44c per share, to $5.04 per share for fiscal 2024. The board declared a quarterly cash dividend of $1.26 per share of FedEx common stock. The dividend is payable July 3 to stockholders of record at the close of business on June 12. The company also announced that its cash-based long-term incentive, or LTI, plan for FY24 through fiscal FY26 will include a return on invested capital, or ROIC, performance metric that will replace the capital expenditures as percentage of revenue performance metric used in recent LTI plans. This change is designed to further align management compensation with stockholder value, with ROIC being a key metric by which to measure the long-term success of FedEx.

07:39 EDT Hochschild Mining terminates option to earn into 60% of Snip Gold Project - Skeena Resources (SKE) announces that, effective immediately, Hochschild Mining (HCHDF) has terminated its option to earn into 60% of the Snip Gold Project in the Golden Triangle of British Columbia, Canada. This results in Skeena reassuming management of the Project and retaining 100% ownership. Hochschild informed Skeena that they have satisfied the minimum annual expenditure requirements as highlighted in Skeena's September 19, 2018 news release. This implies that, at minimum, Hochschild has spent C$15 million on Snip to date. Skeena will receive all data and information generated by Hochschild since their notification of intent to earn into a 60% interest on October 15, 2021.

07:36 EDT Tradeweb Reports March 2023 total trading volume $34.7T, ADV $1.51T - Tradeweb Markets reported total trading volume for March 2023 of $34.7tn. Average daily volume, ADV, for the month was a record $1.51tn, an increase of 23%year-over-year, despite continued foreign exchange headwinds. For the first quarter of 2023, total trading volume was $85.3tn and ADV was a record $1.36tn, an increase of 16.2% YoY, with preliminary average variable fees per million dollars of volume traded of $2.71.1 I

07:35 EDT Conagra Brands narrows FY23 adjusted operating margin view to 15.5%-15.6% - Prior view was 15.3%-15.6%. Sees FY23: Net Leverage Ratio of approximately 3.65x; Capital expenditures of approximately $370M; Interest expense of approximately $410M; Adjusted effective tax rate of approximately 24%; Pension income of approximately $25M.

07:35 EDT Bed Bath & Beyond launches new vendor consignment program with ReStore - Bed Bath & Beyond announced the launch of a new vendor consignment program with ReStore Capital, a Hilco Global company. Under this new, third-party agreement, ReStore Capital will purchase up to $120M, on a revolving basis at any given time, of pre-arranged merchandise from the Company's key suppliers to supplement inventory levels already sold at Bed Bath & Beyond and buybuy BABY. ReStore Capital is a credit-focused investment manager providing creative financing solutions in the consumer, retail, commercial, wholesale and manufacturing industries.

07:34 EDT AutoNation former director and investor Ed Lampert sells $13.1M in common stock - In a regulatory filing last night, AutoNation disclosed that its former director and investor Ed Lampert sold 97.2K shares of common stock on March 31st in a total transaction size of $13.1M.

07:33 EDT Soligenix announces USAN approved "hypericin sodium" as name for new ingredient - Soligenix announced that the United States Adopted Names, or USAN, Council has approved the use of the nonproprietary name of "hypericin sodium" for the novel active ingredient in both HyBryte for the treatment of cutaneous T-cell lymphoma, or CTCL, and SGX302 for the treatment of mild-to-moderate psoriasis. Information on hypericin sodium will be posted on the USAN website before the end of 2023 and will be submitted to the U.S. Pharmacopeial Convention for publication in the U.S. Pharmacopeia Dictionary of USAN and International Drug Names.

07:32 EDT Generation Bio appoints Howze as Chief Legal Officer - Generation Bio (GBIO) announced that Yalonda Howze, J.D. has been appointed chief legal officer and secretary. With nearly two decades of legal experience in the biotechnology and life science sectors, Howze most recently served as chief legal officer, chief compliance officer and corporate secretary of Codiak BioSciences (CDAK).

07:23 EDT Assured Guaranty to combine with Sound Point Capital Management - Assured Guaranty announced an agreement with Sound Point Capital Management, pursuant to which Assured Guaranty will contribute its entire equity interest in Assured Investment Management and, with certain exceptions, its related asset management entities to Sound Point. In addition, U.S. insurers Assured Guaranty Municipal Corp. and Assured Guaranty Corp. will engage Sound Point as their sole alternative credit manager to invest $1B over time in alternative credit strategies, including nearly $400M currently managed by AssuredIM as of December 31, 2022. In exchange, Assured Guaranty will receive a 30% ownership interest in the combined business, subject to potential post-closing adjustments. Assured Guaranty acquired AssuredIM in October 2019. AssuredIM will transfer assets under management of approximately $15.2B, including approximately $14.5B of collateralized loan obligations, or CLOs, as of December 31, 2022, to Sound Point upon completion of the transaction. As a result, Sound Point, which had approximately $21.4B in CLOs and $32B in total AUM as of December 31, 2022, is expected to become the fifth largest CLO manager by AUM in the world. Assured Guaranty expects the transaction to be immediately accretive to earnings per share, return on equity and book value per share, as well as the company's adjusted operating shareholders' equity per share and adjusted book value per share. It also plans to continue its current capital management program, including share repurchases. The transaction is expected to be completed in the third quarter of 2023, subject to certain customary closing conditions, including the receipt of certain consents and regulatory approval. Following closing, Frederico will be appointed to the Sound Point Board of Managers. Assured Healthcare Partners LLC will remain an independent healthcare investment management firm and is not part of the Sound Point transaction. Carried interest associated with Assured Healthcare Partners funds and another single-asset fund in which Assured Guaranty is invested will be retained by Assured Guaranty, as well.

07:14 EDT NFI Group's Alexander Dennis expands Larbert facility for manufacturing - NFI Group subsidiary Alexander Dennis announced plans to expand its Larbert head office and facility into a manufacturing site for the future. The Larbert site will focus on the production of the new Enviro400EV zero-emission bus from August 2023, assembling the next-generation body on the new Alexander Dennis battery-electric chassis. The decision follows a successful pilot program to build Enviro400FCEV hydrogen fuel cell buses in Larbert. The Larbert expansion, which converts existing warehouse space into production lines, supports the company's 690+ green manufacturing jobs in Scotland. The Enviro400EV double deck that will be assembled at Larbert is the crowd-shifter, a core member of the next generation of battery-electric buses from Alexander Dennis. The double deck bus has been designed to move large numbers of people on busy urban corridors and interurban expresses with a total capacity of up to 96 passengers and an operational range of up to 260 miles on a single charge. The Alexander Dennis head office remains at Larbert and work has already been completed to revamp the site's office space to equip it for its future as a flexible environment that brings together key business teams and maximizes utilization under the hybrid working arrangements that are now standard across Alexander Dennis. The changes in Larbert are part of a company-wide modernization journey that started with the opening of the new Farnborough facility in 2022 and which will continue in coming years as further members of the next generation of zero-emission buses are added to the Alexander Dennis portfolio.

07:11 EDT Bellus Health announces results from camlipixant bioavailability study - BELLUS Health announced positive data from its Phase 1 bioavailability equivalence study evaluating a once-daily Extended-Release formulation of camlipixant in comparison to a twice-daily Immediate Release formulation. Camlipixant is the Company's twice-daily, oral P2X3 antagonist product candidate for the treatment of RCC currently being investigated in the CALM Phase 3 program. "We are pleased with the outcome of the bioavailability equivalence study, which establishes the proof of concept for developing a once-daily formulation of camlipixant, our potentially best-in-class P2X3 inhibitor in Phase 3 development," commented Roberto Bellini, President and Chief Executive Officer of BELLUS Health. "At BELLUS Health, we are working to better the lives of individuals suffering from persistent cough, and these results reflect our continued progress to establish and differentiate camlipixant as the market leading option for RCC patients. We look forward to providing additional data from this study at an upcoming medical conference." This Phase 1, open-label bioavailability equivalence study was designed to assess the safety, tolerability, and pharmacokinetic profile of a single dose, once-daily ER formulation of camlipixant versus a twice-daily IR reference formulation in 16 healthy adult subjects.

07:10 EDT Orezone Gold reports Q1 Bombore gold production 41,301 ounces - Orezone Gold provides Q1-2023 production results from its Bombore Gold Mine. Q1-2023 Highlights: Gold production of 41,301 oz.; Gold sales of 43,139 oz at an average realized price of $1,892 per oz resulting in sales proceeds of $81.6M. Cash position of $45.2M at March 31, 2023, an increase of $36M for the quarter. Repaid $9.8M of principal on senior loans. Patrick Downey, President & CEO stated, "Following a successful ramp-up to commercial production in Q4-2022, Q1 marks a strong first full quarter of production at Bombore. The Company remains well-positioned to meet its 2023 annual production guidance of 140,000 to 155,000 ounces, while further reducing its senior debt and improving its treasury. During the quarter, the Bombore mill continued to exceed design by achieving an average throughput of 13% above nameplate capacity while maintaining an average gold recovery of 92.2%. Work on the sulphide expansion study continued during Q1, with metallurgical testwork and flowsheet optimization now complete. The Phase II Sulphide Expansion feasibility study update remains on track for completion in Q3-2023. Lastly, we awarded the main installation contract for grid power connection during the quarter, with orders for major equipment placed. Once the connection is energized in late 2023, a significant reduction to current onsite operating costs can be expected."

07:07 EDT Clearside Biomedical appoints Khanani, Vajzovic to SAB - Clearside Biomedical announced the appointment of Arshad Khanani, M.D., M.A, F.A.S.R.S and Lejla Vajzovic, M.D., F.A.S.R.S to its Scientific Advisory Board, SAB. Khanani is a Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates and Clinical Associate Professor at the University of Nevada, Reno School of Medicine. Lejla Vajzovic is the Director of Duke Vitreoretinal Fellowship Program and is a tenured Associate Professor of Ophthalmology at Duke University.

07:06 EDT Immunic reports CALDOSE-1 trial data, to deprioritize izumerogant development - Immunic reported data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset, vidofludimus calcium, or IMU-838, in patients with moderate-to-severe ulcerative colitis, or UC. The maintenance phase efficacy data at week 50 are as follows: As shown above, data from the maintenance phase of CALDOSE-1 showed a dose-linear increase in clinical remission as compared to placebo at week 50. Moreover, an exploratory statistical analysis confirmed the 30 mg dose of vidofludimus calcium to be statistically superior in achieving clinical remission at week 50, with a 33.7% absolute improvement over placebo. A similar effect on clinical remission rates at week 50 was also found among those patients who received corticosteroids during the induction phase. Finally, a dose-linear increase in endoscopic healing was observed, with the 30 mg dose of vidofludimus calcium being associated with a 37.8% absolute improvement over placebo and also achieving statistical significance in an exploratory statistical analysis. Immunic believes that the maintenance phase data of CALDOSE-1 confirms vidofludimus calcium's impressive activity in the absence of chronic corticosteroid co-administration. Data from the induction phase, released in June of 2022, showed clinical remission rates of 14.7% for the pooled vidofludimus calcium arms and 3.3% for the placebo arm among those patients not being treated concurrently with chronic corticosteroids. At the same time, this benefit was not seen among the population to whom corticosteroids were chronically co-administered. During the maintenance phase, all corticosteroids were required to be tapered, if possible. Hence, the maintenance phase results are in line with the induction data without chronic concomitant use of corticosteroids and underline the performance of vidofludimus calcium in this steroid-free UC population. On a related note, the previous phase 2a ENTRANCE study had already shown that vidofludimus has a high response rate in replacing steroids among steroid-dependent UC patients.Consistent with prior data sets in other patient populations, administration of vidofludimus calcium in the maintenance phase of this trial was observed to be safe and well-tolerated. No new safety signals were observed. The incidence of treatment-emergent adverse events in both the 10 mg and 30 mg dose groups of vidofludimus calcium was comparable with placebo. There were no increased rates of liver events, liver enzyme elevations, renal events or adverse events of special interest, when compared to placebo, and no Hy's Law cases were observed. The CALDOSE-1 trial of vidofludimus calcium in moderate-to-severe UC was a phase 2b, multicenter, randomized, double-blind, placebo-controlled, dose-finding study, including a blinded 10-week induction phase and a blinded 50-week maintenance phase. In the induction phase, 263 UC patients were enrolled at 78 study sites in the United States and Western, Central and Eastern Europe, and patients were randomized into three active dosing arms of 10 mg, 30 mg, 45 mg once-daily, as well as placebo. The primary endpoint comprised a composite of a patient-reported outcome and endoscopy-assessed outcome, also referred to as clinical remission, both evaluated following ten weeks of induction treatment. During the maintenance phase, 112 patients were re-randomized to receive 10 mg or 30 mg once-daily doses of vidofludimus calcium, while placebo patients who achieved symptomatic revision were "sham randomized" to continue receiving placebo in the maintenance phase. In order to focus on the rapidly advancing vidofludimus calcium and IMU-856 programs, and considering the positive results from the CALDOSE-1 trial of vidofludimus calcium in UC, as well as the totality of available data for izumerogant, including changes in expected time to market and increased complexity of potential further development in this competitive field, Immunic has decided to focus its resources and, therefore, deprioritize the clinical portion of its izumerogant development program in psoriasis and castration-resistant prostate cancer. Regarding IMU-856, the company notes that the part C portion of the ongoing phase 1 clinical trial in celiac disease patients has been proceeding more quickly than anticipated, with initial data expected to become available in the current quarter.

07:05 EDT Transcode awarded third year of SBIR grant from NIH to support TTX-MC138 - TransCode Therapeutics announced that it has been awarded the third year of a Fast-Track Small Business Innovation Research, SBIR, grant from the NIH to support the clinical evaluation of TTX-MC138, TransCode's lead therapeutic candidate for the treatment of advanced solid tumors. The award totals nearly $871,000. "We are honored that the NIH recognizes and continues to support our mission to overcome the obstacles of RNA delivery in oncology," said Michael Dudley, President and Chief Executive Officer of TransCode. "We believe our TTX platform offers tremendous potential across a range of indications. Specifically, this third-year tranche of the SBIR grant will help fund the first-in-human study of our lead candidate, TTX-MC138, in patients with metastatic disease. We anticipate receiving Institutional Review Board approval shortly and commencing the clinical trial as soon as practical thereafter."

07:03 EDT Freight reports increase in new clients since Fr8App platform inception - Freight Technologies reports a record increase in the number of new shipper clients added during the month of March 2023. Following a challenging first quarter of the year "We have onboarded new clients in a variety of sectors including automotive, beverage, motorcycles and consumer goods that we had been working on for some time," said Harry Martin, Sales Director for Freight Technologies. "The new shipper clients represent a potential for significant recurring traffic on our platform and include leading first tier automotive clients, renowned motorcycle brands, and cocktail drinks - most of whom are household names. We expect a recurring monthly stream from new accounts to our platform during the month of March of more than $1 million per month, starting to ramp in April." Martin continued, "On the Mexico domestic market, we had confirmations of existing clients for our Fr8fleet business to continue growing through the rest of 2023, and requests for new services from existing shipper clients in the domestic Mexican markets equivalent to almost the entire Fr8fleet 2022 revenue. We have been tirelessly working on getting these key large shipper clients on our platform and we are pleased to announce the signing of a number of key accounts which will help attract carrier activity onto our platform as well. We announced the Kimberly Clark de Mexico multi-year contract earlier this year and anticipate a number of additional announcements in the next 90 days."

07:02 EDT Vertex awarded $440M contract by the U.S. Navy - Vertex, a V2X, was awarded a $440M, contract by the U.S. Navy to provide aircraft maintenance support for Naval Test Wing Pacific, or NTWP, VX-30 and VX-31 at Point Mugu, CA and China Lake, CA. Under this contract, V2X, under its legacy company Vertex, is the chosen provider of flightline maintenance, logistics, and technical support for the two weapons development and test squadrons. This important mission complements NAVAIR's efforts to develop, test and sustain the Navy's most current suite of capabilities. NTWP provides safe, effective, and efficient ground and flight test, airborne flight test support, and experimental operations of manned and unmanned aircraft, weapons, and weapons systems for the Department of the Navy. This contract has a seven-year award period ending in March 2030.

06:59 EDT Hut 8 Mining mined 131 Bitcoin in March - Hut 8 Mining mined 131 Bitcoin in the period ending March 31. In total, 131 Bitcoin were generated, resulting in an average production rate of approximately 4.2 Bitcoin per day. 240 Bitcoin, all of those produced in February, and part of March, were sold in March. Total Bitcoin balance held in reserve as of March 31 is 9,133.

06:51 EDT Miromatrix Medical, CareDx announce exclusive partnership - CareDx (CDNA) and Miromatrix Medical (MIRO) announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human bioengineered organs. CareDx will develop an innovative testing solution for Miromatrix to use in pre-clinical animal models and will be the exclusive provider of donor-derived cell-free DNA testing services for use in human clinical studies to non-invasively assess acute allograft rejection in Miromatrix's pipeline of human bioengineered organs.

06:45 EDT Entain acquires 365scores for $150M plus up to $10M in contingent payments - Entain plc announced that it has acquired the entire issued share capital of 365scores, a sports media business, for a consideration of $150M and contingent payments totaling up to $10M. "365scores is one of the world's leading scores and sports media companies, providing scores & sports information, editorial & social content, as well as sports-focused free-to-play games. They have a fast growing and highly engaged global audience of over 15 million active users and are ranked amongst the top 5 scores apps worldwide. The combination of 365scores' deep expertise in data-driven sports media content alongside Entain's global scale and market leading platform capabilities will provide customers with a broader offering of interactive content and experiences. The acquisition unlocks further growth opportunities and supports our global strategic ambitions," Entain stated.

06:31 EDT Aurinia announces results from AURORA Renal Biopsy Sub-Study - Aurinia Pharmaceuticals announced promising results from the AURORA Renal Biopsy Sub-Study. LUPKYNIS is a novel agent approved for the treatment of adults with active lupus nephritis, or LN. The addition of LUPKYNIS on top of the then current standard of care MMF and low-dose steroids in Aurinia's Phase 3 AURORA 1 and AURORA 2 studies led to significantly earlier and greater reductions in proteinuria while maintaining stable renal function, as evidenced by a stable estimated glomerular filtration rate, or eGFR, slope over time. To further characterize the long-term impact of LUPKYNIS on the kidney at the histologic level, repeat biopsies were collected from selected patients in both treatment arms. The patients in the voclosporin treatment arm demonstrated histologic activity improvement with stable chronicity scores similar to the active control arm of MMF and low dose steroids alone over the 18-months average treatment period at the time of repeat biopsy. Repeat renal biopsies were obtained from 16 patients in the voclosporin arm and 10 patients in the active control arm over 18 months from study entry. Baseline and follow-up activity scores, a measure of active inflammation in LN, and chronicity scores, a measure of irreversible kidney injury, were obtained using a validated assessment tool. Compared to baseline, the activity scores for both LUPKYNIS and active control populations improved to a similar degree, while the chronicity scores remained stable over time in both arms.

06:23 EDT Western Alliance provides quarter-end financial update - Western Alliance Bank on Tuesday provided unaudited financial information as of March 31, 2023: Total insured deposits, including collateralized and pass-through insured deposits, represent approximately 68% of total deposits, significantly higher than year-end. As of quarter-end, immediately available liquidity exceeded uninsured deposits, with a coverage ratio greater than 140%. As of quarter-end, the Bank had no borrowings outstanding from the Federal Reserve's discount window after balance sheet repositioning. Western Alliance expects its CET1 ratio to be materially consistent with year-end 2022. Unrealized losses on Securities and Held for Investment loans have improved since year-end primarily due to lower interest rates, as well as other factors. Kenneth A. Vecchione, President and CEO of Western Alliance Bank, concluded, "Western Alliance's uniquely flexible, diversified business model positioned us to weather the liquidity tightness that enveloped the industry over the past month. Put simply, Western Alliance Bank is different; this diversification continues to distinguish us from monoline or sector-concentrated peer banks. This also demonstrates the value of Western Alliance's scalable national funding channels and allows us to continue to serve clients across sectors, geographies, or macro trends."

06:08 EDT CMS Energy to install 123 new automatic transfer reclosers in 2023 - Consumers Energy announced plans to install 123 new automatic transfer reclosers, or ATRs, in 2023 to help prevent power outages and improve electric reliability for customers. The energy provider's investment in automation is a key part of the company's overall electric reliability plan that aims to reduce both the number and length of power outages.

06:03 EDT KBR named primary project management contractor on BP hydrogen project portfolio - KBR (KBR) announced it has been named the primary integrated project management contractor across BP's (BP) global hydrogen project portfolio. KBR will utilize the collaborative work practices and experience of its Integrated Project Management Team, or IPMT. The IPMT will provide services required for project delivery, including performance management of individual projects and relevant subcontractors. The contract scope includes joint contribution to front-end, optimization and execution project phases as well as management support through construction, commissioning and startup for BP's global hydrogen projects. The contract will commence under the existing global agreement with BP.